Lupus Nephritis, the therapy and the role of Rituximab in resistant cases
Background Systemic lupus erythematosus (SLE) is a common autoimmune disease that affects mainly young females and nephritis is an important complication of the disease that may end with end stage renal disease (ESRD). Early diagnosis and proper treatment is important in decreasing the morbidity. Mu...
Main Authors: | Hussein A. Nasir, Yasir F. Sharba, Nadia A. Nasir |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Medicine University of Baghdad
2014-01-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/574 |
Similar Items
-
USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01) -
Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01) -
Lupus nephritis - case report of an uncommon succession of therapies
by: Andreea Rovinaru, et al.
Published: (2023-12-01) -
Lupus nephritis : frontiers and challenges /
by: Sheashaa, Hussein A.
Published: (2010) -
Clinical And Morphological Improvement Of Lupus Nephritis Treated With Rituximab
by: Tsanyan Maria E., et al.
Published: (2014-12-01)